Lu Shi

Addition of Low-Dose Decitabine to Anti–PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin Lymphoma

Jing Nie, Chunmeng Wang, Yang Liu et al. · Journal of Clinical Oncology · 2019 · 214 citations · Full text

Ferulic acid exhibits anti-inflammatory effects by inducing autophagy and blocking NLRP3 inflammasome activation

Yongjuan Liu, Lu Shi, Wenhong Qiu et al. · Molecular & Cellular Toxicology · 2022 · 86 citations · Full text

Inflammation, Cell Autophagy, Anti-inflammatory +13

Quantitative determination of carcinogenic mycotoxins in human and animal biological matrices and animal-derived foods using multi-mycotoxin and analyte-specific high performance liquid chromatography-tandem mass spectrometric methods

Xiaoqin Cao, Xiaofei Li, Jian Li et al. · Journal of Chromatography B · 2017 · 70 citations

Animal-derived Foods, Medicine, Mycotoxin Formation +11

Increased IFNγ+ T Cells Are Responsible for the Clinical Responses of Low-Dose DNA-Demethylating Agent Decitabine Antitumor Therapy

Xiang Li, Yan Zhang, Meixia Chen et al. · Clinical Cancer Research · 2017 · 57 citations · Full text

Cell Therapy, Immunology, Immunoediting +16

Teprotumumab for non-inflammatory thyroid eye disease (TED): evidence for increased IGF-1R expression

Shoaib Ugradar, Lu Shi, Yao Wang et al. · Eye · 2020 · 51 citations · Full text

Inflammation, Ocular Disease, Autoimmune Disease +8